SUPPLY OF BOTULISM ANTITOXIN HEPTEVALENT (HBAT)
Estimated value
—
goods
Awarded value
—
Suppliers
1
Lots
1
1 awarded
Published
20 Jun 2022
Description
The Chemical, Biological, Radiological and Nuclear (CBRN) team, part of Defence Equipment and Support (DE&S) organisation within the UK Ministry of Defence (MOD), intends to place a contract with Emergent Biosolutions Canada Inc for the supply of Heptavalent Botulism Antitoxin (HBAT) for a period of 10 years (5 + 5 Option Years) with an estimated value of £20m. This is necessary to ensure maintenance of the capability with an acceptable stockholding level.
Scope
- Reference
- ocds-h6vhtk-034881
- Commercial tool
- Standalone contract
- Main category
- goods
- Contract locations
- CA
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| Lowest price | — | price | — |
Submission & procedure
- Procedure
- Negotiated without publication of a contract notice
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Awarded to